Economic Factors Affecting the Seasonal Influenza Vaccination Market in East Europe: Ken Research REQUEST FOR SAMPLE REPORT Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit In 2009, a recommendation of the European Union (EU) health Council was issued in order to increase the vaccination of risk groups and healthcare workers in addition to further technical and scientific expertise. The essentiality of this guidance was to provide the EU Member States with relevant information regarding the decision-making process on routine vaccination of healthy children, adults and pregnant women with seasonal influenza vaccine, giving a flourishing push to the market of seasonal influenza vaccination. Collectively referring to the Eastern European countries of Romania, Hungary, Slovenia and Slovakia, wherein the seasonal vaccination is recommended for children, the latter for ages>6 months to <13 years and the former for ages>6 months to <3 years, with no reimbursement of vaccine costs. Within these specific countries, the vaccination policy of Slovenia differs from the rest by mandating the childhood vaccination across nine areas to be necessary with excluding the exceptions based on religious belief along with the implementation of fines for those who fail to comply, thus giving a further impetus to the growth of the market. The remaining countries followed the recommendations of those aged >60 in Hungary and >65 in Romania. According to a recent article published by ken research, it can be conferred that in terms of children vaccination, Romania & Hungary together accounts for more than 40 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 80 percent market share by 2022. Furthermore, only the country of Romania is provided with the public funding for the vaccine. Therefore, it can be accomplished that Romania is having the highest seasonal influenza vaccine market share in East Europe Countries, as mentioned in the Ken Research report. Ken Research says, in order for the systematic review of the search strings for influenza, geographical scope, burden of influenza, vaccine safety, vaccine effectiveness, and cost effectiveness, PubMed was used as the core database along with Embase for the influenza burden in pregnant women. For the fulfillment of the purpose, these search strings were combined with search strings for population, i.e. children, adults, pregnant women and contact of young children. The European Union (EU) recommendation for the influenza virus strains has been issued by the European Medicines Agency that should be included in the vaccines for the prevention of seasonal influenza from the autumn of 2017. According to the report “Seasonal Influenza Vaccination Market in Hungary, Romania, Slovakia Slovenia (East Europe) By (Infant & Adult) Forecast”, the effective growth of the seasonal influenza vaccination industry can be attributed to many factors, such as the increasing burden of the seasonal influenza, technological and scientific advancements with new vaccines uncovering the surface, increasing health awareness among consumers, desire to live healthy lives with the increasing expenditure ability, etc. resulting in the increased involvement of the younger patients along with their families undergoing vaccinations. Their market is also well assisted by the recent biotechnological developments. The impetus growth can also be attributed to the continuous rise in the occurrence of a range of seasonal influenza requiring vaccination aided by the various governmental policies launching targeted vaccination programs. However, vaccinating all children would lead to herd immunity thus reducing overall transmission of influenza. Also, the introduction of universal influenza vaccination of children affects the overall childhood vaccination schedule and hardly any European studies regarding the vaccine effectiveness have been identified in children along with no post-vaccine safety studies, further resulting in the constricted extension of the market. Key topics covered in report Influenza Vaccine Market Research Report Influenza Vaccine Market in Hungary Influenza Vaccine Market in Romania Influenza Vaccine Market in Slovakia Global Influenza Vaccine Industry Influenza Vaccination Market in East Europe East Europe Influenza Vaccination Market Size East Europe Influenza Vaccination Market Outlook East Europe Influenza Vaccination Market Players For more coverage click on the link below: https://www.kenresearch.com/healthcare/pharmaceuticals/seasonal-influenza-vaccination-market/88378-91.html Related Reports https://www.kenresearch.com/healthcare/pharmaceuticals/europe-proton-therapy-market-forecast/104295-91.html https://www.kenresearch.com/healthcare/pharmaceuticals/influenza-vaccine-market-forecast/104294-91.html Contact Us: Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Tags: East Europe Influenza Vaccination Market Outlook, East Europe Influenza Vaccination Market Players, East Europe Influenza Vaccination Market Size, Global Influenza Vaccine Industry, Influenza Vaccination Market in East Europe, Influenza Vaccine Market in Hungary, Influenza Vaccine Market in Romania, Influenza Vaccine Market in Slovakia, Influenza Vaccine Market Research Report